Zydus Lifesciences‘ share price continued its upward momentum for a second straight day, climbing 1% in early trading on 15 April after receiving approval from...
India’s pharmaceutical industry is on the rise, with its top companies becoming key players on the global stage. Behind their success lies a blend of...
Zydus Lifesciences Ltd announced on Friday that the United States Food and Drug Administration (USFDA) has successfully completed an inspection of its Ahmedabad facility without...
Shilpa Medicare, in partnership with the Zydus Group through their joint venture Oncosol, and its collaborator Shorla Oncology, announced on November 27 that the USFDA...
Shares of Zydus Lifesciences Ltd. ended flat after hitting a day’s high of Rs 1,070.50 on 11th October, despite the firm announcing yesterday that it...